3.99000 USD
0.55
12.11%
Last update Dec 15, 3:59 PM EST
Post-market
Day range
3.97000
4.70000
Previous close
4.54000
Open
4.62000
Access this stock data via API
Subscribe
Aldeyra Therapeutics Inc.
3.99
0.55
12.11%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 48.2M 29.5M 47.3M 44.9M
Selling general and admin 11.9M 13.3M 15.4M 11.3M
Other operating expenses
Operating income -60.1M -42.8M -62.7M -56.2M
Non operating interest income
Income 6.2M 7.3M 2.3M 185.4K
Expense 1.9M 2.1M 1.7M 1.7M
Other income expense
Pretax income -55.9M -37.5M -62.0M -57.8M
Tax provision 0
Net income -55.9M -37.5M -62.0M -57.8M
Basic EPS -0.9 -0.6 -1.1 -1.1
Diluted EPS -0.9 -0.6 -1.1 -1.1
Basic average shares 59.5M 58.9M 58.4M 54.0M
Diluted average shares 59.5M 58.9M 58.4M 54.0M
EBITDA -53.7M -35.2M -60.1M -55.8M
Net income from continuing op. -55.9M -37.5M -62.0M -57.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 27 minutes

19:33
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).